Patent details

LUC00071 Product Name: An antibody comprising a complementary determining region light chain 1 (CDRL1) amino acid sequence of SEQ ID NO:50, a CDRL2 amino acid sequence of SEQ ID NO:56, and a CDRL3 amino acid sequence of SEQ ID NO:73, and a complementary determining region heavy chain 1 (CDRH1) amino acid sequence of SEQ ID NO:5; a CDRH2 amino acid sequence of SEQ ID NO:20; and a CDRH3 amino acid sequence of SEQ ID NO:44; such as an antibody comprising a light chain variable region comprising an amino acid sequence of SEQ ID NO:116 and a heavy chain variable region comprising an amino acid sequence of SEQ ID NO: 106, in particular guselkumab.

Basic Information

Publication number:
LUC00071
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP068468362
Legal Status:
Inactive
Application number:
LUC00071
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/17/1234
Marketing Authorization Type:
Marketing Authorization Date:
14/11/2017
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
25/04/2018
First Marketing Authorization date:
14/11/2017
Grant date:
28/06/2018
Activation date:
Publication date:
02/05/2018
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
28/12/2031
SPC Extension Expiration:
28/12/2031
Rejection date:
Withdrawal date:

Owner

From:
25/04/2018
 
 

Name:
Janssen Biotech, Inc.
Address:
800/850 Ridgeview Drive, Horsham, PA 19044, United States (US)

Agent

Name:
DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
From:
25/04/2018
Address:
PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2018/07
Publication date:
21/06/2018
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2018/08
Publication date:
06/07/2018
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
31/12/2026
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
02/05/2018 Publication 1
02/05/2018 Outgoing Correspondence 1
28/06/2018 Certificate 2
28/06/2018 Publication 1